Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-acetamido-2-deoxy-beta-D-glucopyranose(beta1-4)-2-acetamido-1,6-anhydro-3-O-[(R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose-L-alanyl-gamma-D-glutamyl-meso-diaminopimelyl-D-alanine
- Development stage
- Unknown
- Modality
- Peptides, Small Molecules
01
Overview
This compound is a synthetic peptidoglycan fragment that mimics the structure of bacterial cell wall components. It consists of two N-acetylglucosamine (GlcNAc) residues linked beta(1→4), with one residue further modified and attached to a peptide chain composed of L-alanine, gamma-D-glutamic acid, meso-diaminopimelic acid, and D-alanine. Such structures are typically used in research as substrates or inhibitors for enzymes involved in bacterial cell wall biosynthesis (e.g., transpeptidases or lysozymes), or as immunological probes to study innate immune recognition of bacterial peptidoglycan. The compound is classified as an experimental small molecule and oligopeptide[2].
- Other names
- DB04736DB-04736DB 04736
Beyond the preview
Go deeper on 2-acetamido-2-deoxy-beta-D-glucopyranose(beta1-4)-2-acetamido-1,6-anhydro-3-O-[(R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose-L-alanyl-gamma-D-glutamyl-meso-diaminopimelyl-D-alanine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-acetamido-2-deoxy-beta-D-glucopyranose(beta1-4)-2-acetamido-1,6-anhydro-3-O-[(R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose-L-alanyl-gamma-D-glutamyl-meso-diaminopimelyl-D-alanine.